Unclaimed brand
Clinical-stage biopharmaceutical company focused on the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Nasdaq $ALZN
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#510C76
Windsor
81, 12, 118
279, 82, 25
31, 90, 0, 54
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#3A0656
Clairvoyant
58, 6, 86
279, 87, 18
33, 93, 0, 66
Alzamend Neuro Inc., headquartered in Atlanta, Georgia, is a clinical-stage biopharmaceutical company dedicated to finding safe and effective treatments for Alzheimer's disease and other psychiatric disorders. Our mission is to Make Alzheimer's Just a Memory™ by rapidly developing and marketing innovative solutions. We firmly believe that robust research support is crucial for true innovation.
This belief allows us to gain unique insights and effectively address the unmet needs of the patients we serve. With a deep commitment to the well-being of those affected by Alzheimer's, we are determined to make a significant impact on the lives of millions of people globally. At Alzamend Neuro, we are actively engaged in developing a comprehensive product pipeline that includes cutting-edge treatments for Alzheimer's and other mental health conditions.
Through our unwavering dedication to science and clinical advancements, we strive to provide hope and make a lasting difference in the lives of patients and their families. Join us in our mission to transform the field of neurology and improve the lives of those affected by cognitive disorders
Company type
Public Company
Year founded
2016
Company size
2-10 employees
Alzheimer’s drug development
Lithium ionic cocrystal therapeutics
Alzheimer’s immunotherapy vaccines
Bipolar disorder therapeutics
PTSD drug development